Masimo fight over watch‑based blood‑oxygen monitoring has escalated with a $634 million jury award and a fresh ITC review of Apple’s workaround.
Health and Me on MSN
Common Blood Pressure Drug Hydralazine Could Slow Down Cancer
Scientists accidentally discovered that a common blood pressure drug called hydralazine could actually slow down fast-growing cancer. The cancer cell in this study is specifically glioblastoma, a form ...
Scientists accidentally discovered how an old blood pressure drug hydralazine could fight aggressive brain cancer by ...
A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million ...
A federal jury finds that the Apple Watch’s workout mode and heart-rate notification features violate patents held by medical ...
A federal jury in California has ordered Apple to pay $634 million to Masimo Corporation for infringing patents related to blood oxygen monitoring technology us ...
Throughout the year, Niterra introduced 36 new oxygen sensors, with an additional 16 launched on Oct. 29. The total 52 new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback